beta-D-Galactopyranoside, 1-methylethyl 1-thio-

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: beta-D-Galactopyranoside, 1-methylethyl 1-thio-
• 英文别名: 2-(hydroxymethyl)-6-propan-2-ylsulfanyloxane-3,4,5-triol
• 化学式: C₉H₁₈O₅S
• mdl: MFCD24389442
• 分子量: 238.3
• InChiKey: BPHPUYQFMNQIOC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.5
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  115
• 氢给体数：
  4
• 氢受体数：
  6

文献信息

• [EN] TIMOSAPONIN COMPOUNDS<br/>[FR] COMPOSÉS TIMOSAPONINE
  申请人：CHE CHIMING

  公开号：WO2013149580A1

  公开（公告）日：2013-10-10

  Provided herein are timosaponin compounds of Frmula I, II, IIΙ, I', II' and IIΙ', pharmaceutical compositions comprising the coumpounds, and processes of preparation thereof. Also provided are uses of said timosaponin compounds for preparing medicament for the treatment of diseases associated with beta-amyloid in hosts or subjects in need thereof.

  提供的是I、II、IIΙ、I'、II'和IIΙ'公式的地高辛化合物，包括所述化合物的药物组合物及其制备方法。还提供了所述地高辛化合物用于制备用于治疗与宿主或需要的人体中的β-淀粉样蛋白相关的疾病的药物。
• Novel aromatic fluoroglycoside derivatives, pharmaceuticals comprising said compounds and the use thereof
  申请人：FRICK Wendelin

  公开号：US20110059910A1

  公开（公告）日：2011-03-10

  The invention relates to substituted aromatic fluoroglycoside derivatives, and to the physiologically compatible salts and physiologically functional derivatives thereof. The invention also relates to methods of lowering blood sugar and the treatment of type I and type II diabetes.

  这项发明涉及取代芳香族氟糖苷衍生物，以及其生理兼容盐和生理功能衍生物。该发明还涉及降低血糖和治疗I型和II型糖尿病的方法。
• TIMOSAPONIN COMPOUNDS
  申请人：Che Chiming

  公开号：US20150050367A1

  公开（公告）日：2015-02-19

  Provided herein are timosaponin compounds of Formula I, II, III, I′, II′ and III′, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are uses of said timosaponin compounds for preparing medicament for the treatment of diseases associated with beta-amyloid in hosts or subjects in need thereof.

  本文提供了公式I、II、III、I'、II'和III'的timosaponin化合物、含有该化合物的制药组合物以及其制备过程。还提供了使用该timosaponin化合物制备药物用于治疗与beta-淀粉样蛋白在宿主或需要该药物的受试者相关的疾病的用途。
• Desferrithiocin analogs and uses thereof
  申请人：University of Florida Research Foundation, Incorporated

  公开号：US10010535B2

  公开（公告）日：2018-07-03

  Iron overload is associated with pathological conditions such as oxidative stress, transfusional iron overload, thalassemia, primary hemochromatosis, secondary hemochromatosis, diabetes, liver disease, heart disease, cancer, radiation injury, neurological or neurodegenerative disorder, Friedreich's ataxia (FRDA), macular degeneration, closed head injury, irritable bowel disease, and reperfusion injury. The present invention provides methods and pharmaceutical compositions using desferrithiocin analogs of Formulae (A) and (J) for treating and/or preventing these pathological conditions, metal (e.g., iron, aluminum, a lanthanide, or an actinide (e.g., uranium)) overload conditions, and infectious diseases (e.g., malaria).

  铁超载与氧化应激、输血铁超载、地中海贫血、原发性血色素沉着病、继发性血色素沉着病、糖尿病、肝病、心脏病、癌症、辐射损伤、神经或神经退行性疾病、弗里德里希共济失调（FRDA）、黄斑变性、闭合性头部损伤、肠易激性疾病和再灌注损伤等病理状况有关。本发明提供了使用式（A）和式（J）的去铁硫霉素类似物治疗和/或预防这些病理状况、金属（如铁、铝、镧系元素或锕系元素（如铀））过载状况和传染病（如疟疾）的方法和药物组合物。
• Timosaponin compounds
  申请人：Che Chiming

  公开号：US11319338B2

  公开（公告）日：2022-05-03

  Provided herein are timosaponin compounds of Formula I, II, III, I′, II′ and III′, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are uses of said timosaponin compounds for preparing medicament for the treatment of diseases associated with beta-amyloid in hosts or subjects in need thereof.

  本文提供了式Ⅰ、Ⅱ、Ⅲ、Ⅰ′、Ⅱ′和Ⅲ′的噻吗皂苷化合物、包含这些化合物的药物组合物及其制备工艺。还提供了所述替莫索皂苷化合物用于制备治疗宿主或有需要的受试者与β-淀粉样蛋白相关疾病的药物的用途。